Collplant Holdings Ltd
From Verify.Wiki
 | |
| | |
| Collplant Holdings Ltd | |
|---|---|
| Type | Public |
| Industry | Medical Device, Health Care, Biotechnology |
| Founded | 2004 |
| Slogan | Revolutionizing Tissue Repair |
| Headquarters | Ness Ziona, HaMerkaz, Israel |
| Key people | Oded Shoseyov (Founder), Yehiel Tal (CEO), Eran Rotem (CFO), Dr. Ilana Belzar (COO) [1] |
| Investors | Docor International Management, Meitav Underwriting, Modgal Industries, Pontifax [2] |
| Number of employees | 37 [3] |
CollPlant Holdings Ltd. produces and distributes pharmaceutical products. The Company offers wound care, orthopedics, and tissue repair medicines. CollPlant Holdings conducts its business in the United States. [4]
It is a medical device company focused on advancing regenerative medicine by utilizing its proprietary processing technologies for human collagen and other recombinant proteins. The company is developing a substantial range of biomaterials-based products applicable in multiple medical markets, including orthopaedics, wound management, cardiology and general surgery.
Collplant Holdings recently filed for U.S. IPO on Oct 21, 2016, applied to list ADSS on Nasdaq, under symbol "CLGN"; Ladenburg Thalmann and Roth Capital are underwriter
Contents
[hide]History[edit | edit source]
- 2006 - Collplant raises $1.5M via Pontifax[5]
- 2007 - Collplant raises $2M via Pontifax, Meitav Underwriting and Modgal Industries[6]
- 2007 - Collplant raises $4.5M via Pontifax and Docor International Management[7]
- 2008 - Collplant raises $8.3M via Pontifax and Docor International Management[8]
- 2010 - Collplant raises $2m via Pontifax Fund, Meitav Underwriting, Modgal, and private investors
- Feb 2016 - CollPlant receives CE Mark for Vergenix™FG Wound Filler
- June 2016 - CollPlant Signs distribution agreement in Italy for Vergenix®FG Wound Care Product
- Oct 2016 - Collplant files for U.S. IPO
Controversies[edit | edit source]
Top 5 Recent Tweets[edit | edit source]
| Date | Author | Comment |
|---|---|---|
| December 01, 2022 | AlertTrade | 🔎 Trending Stocks : $CLGN CollPlant Holdings Ltd #TrendingStocks May 23, 2022 08:00:00 am https://t.co/AOmRDbNyhT |
Top 5 Recent News Headlines[edit | edit source]
- Collplant Holdings files for U.S. IPO - Collplant Holdings files for U.S. IPO; applied to list ADSS on Nasdaq, under symbol "CLGN"; Ladenburg Thalmann and Roth Capital are underwriters. [9]
- CollPlant announces Commencement of Commercial Treatments of Vergenix®FG Wound Filler in Europe - The company announced the commencement of commercial treatments of Vergenix®FG (Flowable Gel) wound filler in patients in Italy. [10]
- CollPlant Reaches Commercial Milestone: Company Signs distribution agreement in Italy for Vergenix®FG Wound Care Product - This is an exclusive, two year agreement, with an option to extend the period. CollPlant expects the first order to be received within the next few days, with delivery of products scheduled for June 2016. [11]
- CollPlant receives CE Mark for Vergenix™FG Wound Filler - This marks the achievement of a significant milestone and paves the way for sales to begin in Europe in coming months. [12]
- CollPlant Reports Positive Final Trial Results for Vergenix™STR, Indicated for the Treatment of Tendinopathy - Clinical Success Demonstrated, with Improvement in Pain and Functionality at Three and Six-month Follow-ups. [13]
References[edit | edit source]
- Jump up ↑ http://www.collplant.com/about/#management-team
- Jump up ↑ https://www.crunchbase.com/organization/collplant#/entity
- Jump up ↑ http://www.nasdaq.com/markets/ipos/company/collplant-holdings-ltd-958513-81929
- Jump up ↑ http://www.bloomberg.com/quote/PTGN/L:IT
- Jump up ↑ https://www.crunchbase.com/funding-round/5aa7b03fb6c6c9616c1ed44426c4e2bb
- Jump up ↑ https://www.crunchbase.com/funding-round/63230326cd63fa0b8a8acc54fc0a6bd6
- Jump up ↑ https://www.crunchbase.com/funding-round/c1f0abc1aa1efedac88863427ab0c742
- Jump up ↑ https://www.crunchbase.com/funding-round/4899826098b8ed66fb84cdb569c9ee5d
- Jump up ↑ http://in.reuters.com/article/idINFWN1CR0HI
- Jump up ↑ http://www.collplant.com/news/collplant-announces-commencement-of-commercial-treatments-of-vergenixfg-wound-filler-in-europe/
- Jump up ↑ http://www.collplant.com/news/collplant-reaches-commercial-milestone-company-signs-distribution-agreement-in-italy-for-vergenixfg-wound-care-product/
- Jump up ↑ http://www.collplant.com/news/collplant-receives-ce-mark-for-vergenix-fg-wound-filler/
- Jump up ↑ http://www.collplant.com/news/collplant-reports-positive-final-trial-results-for-vergenixstr-indicated-for-the-treatment-of-tendinopathy/
